RESEARCH-USE BIOSIMILAR ANTIBODY
Semzuvolimab
Monoclonal antibody · IgG1
Semzuvolimab is a human IgG1κ antibody, targeting to p55, T cell surface antigen T4/Leu-3 (CD4). Human CD4 antibodies can neutralize HIV infection and have the potential to inhibit HAART stable HIV infection.
TARGETCD4
YMonoclonal antibody
CATALOGSC-BS-172
CATALOG NUMBERSC-BS-172
MOLECULAR WEIGHTApprox. 145.15 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Semzuvolimab is a human IgG1κ antibody, targeting to p55, T cell surface antigen T4/Leu-3 (CD4). Human CD4 antibodies can neutralize HIV infection and have the potential to inhibit HAART stable HIV infection.
Semzuvolimab is a recombinant research-use antibody directed against CD4.